S100A16 and endocervical adenocarcinoma: Screening GEPIA database information showed that S100A16 expression was up-regulated in BLCA (Bladder Urothelial Carcinoma), CESC (Cervical squamous cell carcinoma and endocervical adenocarcinoma), COAD (Colon adenocarcinoma), DLBC (Lymphoma Diffuse Large B Somatic Lymphoma), GBM (Glioblastoma multiforme), LGG (Brain Lower Grade Glioma), LUSC (Lung squamous cell carcinoma), OV (Ovarian serous cystadenocarcinoma), PAAD (pancreatic tumor), READ (Rectum adenocarcinoma), STAD (rectal cancer), THYM (thymoma).